KalVista Pharmaceuticals Announces Changes to Board of Directors
– Patrick A. Treanor Appointed Effective Immediately – – Dan Soland Resigns in Planned Transition – CAMBRIDGE, Mass. & SALISBURY, England–(BUSINESS WIRE)–$KALV–KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today announced that Patrick A. Treanor has been appointed and Dan … [Read more…]